Naperville, IL -- (SBWIRE) -- 02/24/2014 -- Reportstack, provider of premium market research reports announces the addition of PharmaPoint: Obesity - Japan Drug Forecast and Market Analysis to 2022 market report to its offering
PharmaPoint: Obesity - Japan Drug Forecast and Market Analysis to 2022
After a more than decade long dormancy, the Obesity market is undergoing a revival with the advent of several novel therapies that will lend considerable visibility to this indication space. This includes the use of combination therapies that simultaneously target multiple pathways and regulate appetite control, as well as novel molecular entities with new mechanisms of action. Due to this growing pipeline of late-stage drugs, this market is expected to experience substantial growth over the next decade.
Until the late 1990s, Japans pharmaceutical market structure differed greatly from that of the rest of the world, particularly western countries. The drug approval process was very slow and gave preference to domestic producers. Regulators and physicians were highly risk-averse, and the NHI system insulated manufacturers from the demands of the market. These factors combined to create an uncompetitive industry and subpar products.
- Overview of Obesity including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
- Detailed information on the key drugs in Japan including product description, safety and efficacy profiles as well as a SWOT analysis.
- Sales forecast for the top drugs in Japan from 2012-2022.
- Analysis of the impact of key events as well the drivers and restraints affecting the Japan Obesity market.
Reasons to buy
- Understand and capitalize by identifying products that are most likely to ensure a robust return.
- Stay ahead of the competition by understanding the changing competitive landscape for Obesity.
- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential.
- Make more informed business decisions from insightful and in-depth analysis of drug performance.
- Obtain sales forecast for drugs from 2012-2022 in Japan.
To view the table of contents for this market research report please visit
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)